Search

Search Results

• 

  Classification and clinical assessment

  A. Marchesoni, F. Cantini

  79-87

  05-06-2012

  https://doi.org/10.4081/reumatismo.2012.79

  1249

  PDF: 2013
• 

  A clinical overview of bone marrow edema

  M. Manara, M. Varenna

  184-196

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.790

  11256

  PDF: 5620

• Effects of estrogen peripheral metabolism in rheumatoid arthritis

  S. Capellino, P. Montagna, B. Villaggio, M. Cutolo

  78-82

  https://doi.org/10.4081/reumatismo.2005.78

  1361

  PDF: 1894
• 

  The role of leukemia inhibitory factor in autoimmune disorders: insights into recovery and treatment

  Zahra Rodgarpoor, Ahmad Meshkin, Mohammadamin Ehramianpour, Fateme Zare

  01-04-2025

  https://doi.org/10.4081/reumatismo.2025.1753

  1211

  PDF: 375
• 

  Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies

  E. Shahi, C. Donati, M. Gattinara, I. Pontikaki, V. Gerloni

  97-100

  https://doi.org/10.4081/reumatismo.2011.97

  1394

  PDF: 877

• Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disabilty

  G. Cuomo, P. Di Micco, A. Niglio, G. La Montagna, G. Valentini

  242-246

  https://doi.org/10.4081/reumatismo.2004.242

  1510

  PDF: 1287

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  https://doi.org/10.4081/reumatismo.2008.290

  2075

  PDF: 1083

• TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

  I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

  275-282

  https://doi.org/10.4081/reumatismo.2006.275

  1051

  PDF: 944

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  https://doi.org/10.4081/reumatismo.2004.1s.51

  718

  PDF: 713

• TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: preliminary results

  M. Fabris, E. Di Poi, S. Sacco, G. Damante, L. Sinigaglia, G. Ferraccioli

  19-26

  https://doi.org/10.4081/reumatismo.2002.19

  1295

  PDF: 767
• 

  Thermal alterations in patients with inflammatory diseases: a comparison between psoriatic and rheumatoid arthritis

  A. Capo, J. Di Paolo, E. Celletti, E. Ismail, A. Merla, P. Amerio

  225-231

  20-12-2018

  https://doi.org/10.4081/reumatismo.2018.1050

  1506

  PDF: 1019

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  https://doi.org/10.4081/reumatismo.2010.101

  1679

  PDF: 1021

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  https://doi.org/10.4081/reumatismo.2006.121

  1758

  PDF: 1722

• Accuracy and standardization of diagnostic methods for the detection of antibodies to citrullinated peptides

  N. Bizzaro, M. Tampoia

  222-228

  https://doi.org/10.4081/reumatismo.2009.222

  1085

  PDF: 866

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  https://doi.org/10.4081/reumatismo.2004.1s.46

  699

  PDF: 695

• Role of chemokines in the pathogenesis of rheumatoid synovitis

  F. Ingegnoli, A. Manzo, F. Fantini, R. Caporali, C. Montecucco, N. Pipitone, C. Pitzalis

  12-18

  https://doi.org/10.4081/reumatismo.2002.12

  790

  PDF: 818

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  https://doi.org/10.4081/reumatismo.2008.41

  1173

  PDF: 804
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  3794

  PDF: 550

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  https://doi.org/10.4081/reumatismo.2009.107

  1916

  PDF: 1164

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  https://doi.org/10.4081/reumatismo.2005.16

  972

  PDF: 903
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  https://doi.org/10.4081/reumatismo.2011.18

  1302

  PDF: 968

• Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

  A. Spadaro, V. Riccieri, C. Alessandri, R. Scrivo, G. Valesini

  116-120

  https://doi.org/10.4081/reumatismo.2006.116

  1214

  PDF: 1198

• “THE LEEDS IDEA”: AN HISTORICAL ACCOUNT OF THE SPONDARTHRITIS CONCEPT

  J.M.H. Moll

  13-18

  https://doi.org/10.4081/reumatismo.2007.1s.13

  809

  PDF: 782

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1036

  PDF: 1003

• IL-1Ra: its role in rheumatoid arthritis

  M. Cutolo

  41-45

  https://doi.org/10.4081/reumatismo.2004.1s.41

  1481

  PDF: 2322

• Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco

  12-33

  https://doi.org/10.4081/reumatismo.2010.12

  1514

  PDF: 1231

• Rheumatoid arthritis and atherosclerosis

  B. Seriolo, A. Sulli, B. Burroni, M. Cutolo

  140-146

  https://doi.org/10.4081/reumatismo.2003.140

  1847

  PDF: 2945

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  https://doi.org/10.4081/reumatismo.2009.65

  1352

  PDF: 1063

• Disability and quality of life of patients with rheumatoid arthritis: assessment and perspectives

  F. Salaffi, A. Stancati

  87-106

  https://doi.org/10.4081/reumatismo.2004.1s.87

  1305

  PDF: 3395
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1154

  1587

  PDF: 1114

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  https://doi.org/10.4081/reumatismo.2010.292

  1783

  PDF: 1939

• Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis

  G.L. Erre, A. Tocco, R. Faedda, A. Cossu, A. Carcassi

  118-123

  https://doi.org/10.4081/reumatismo.2004.118

  1047

  PDF: 5838
• 

  A case of false positive Troponin I in a patient affected by cryoglobulinemic vasculitis

  M. Bellan, M. Pirisi, G. Bellomo, P.P. Sainaghi

  40-42

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.941

  1332

  PDF: 745

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  https://doi.org/10.4081/reumatismo.2009.197

  1183

  PDF: 914

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  https://doi.org/10.4081/reumatismo.2007.235

  1507

  PDF: 976

• Comorbidities in rheumatoid arthritis: analysis of hospital discharge records

  M. Parodi, L. Bensi, T. Maio, G.S. Mela, M.A. Cimmino

  154-160

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.154

  2065

  PDF: 1458

• Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

  D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1658

  862

  PDF: 246
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1243

  1567

  PDF: 754
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.155

  2346

  PDF: 1600

• The rehabilitative approach in rheumatoid arthritis

  G. Arioli, S. Maddali Bongi, N. Pappone

  242-248

  https://doi.org/10.4081/reumatismo.2008.242

  1753

  PDF: 1987

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  https://doi.org/10.4081/reumatismo.2004.1s.28

  995

  PDF: 2947

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  https://doi.org/10.4081/reumatismo.2001.215

  1096

  PDF: 745

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  https://doi.org/10.4081/reumatismo.2005.273

  794

  PDF: 2290

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  https://doi.org/10.4081/reumatismo.2009.48

  1435

  PDF: 1001

• Prevalence of anti-CCP antibodies in systemic sclerosis

  M. Marrone, A. Chialà, M. Tampoia, F. Iannone, L. Raho, M. Covelli, V. Grattagliano, N. Pansini, G. Lapadula

  20-24

  https://doi.org/10.4081/reumatismo.2007.20

  1137

  PDF: 858

• Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide

  M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli

  94-103

  https://doi.org/10.4081/reumatismo.2004.94

  1356

  PDF: 932
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.922

  4580

  PDF: 3073
• 

  Cardiovascular involvement in psoriatic arthritis

  F. Atzeni, M. Turiel, L. Boccassini, S. Sitia, L. Tomasoni, M. Battellino, A. Marchesoni, V. De Gennaro Colonna, P. Sarzi-Puttini

  148-154

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.148

  1952

  PDF: 1003

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  https://doi.org/10.4081/reumatismo.2001.204

  1376

  PDF: 891

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  306-308

  https://doi.org/10.4081/reumatismo.2009.306

  976

  PDF: 791